Anika Therapeutics Inc. (ANIK): Price and Financial Metrics


Anika Therapeutics Inc. (ANIK): $40.02

-0.46 (-1.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ANIK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 505

in industry

ANIK POWR Grades


  • ANIK scores best on the Value dimension, with a Value rank ahead of 82.15% of US stocks.
  • ANIK's strongest trending metric is Quality; it's been moving down over the last 48 weeks.
  • ANIK's current lowest rank is in the Sentiment metric (where it is better than 38.52% of US stocks).

ANIK Stock Summary

  • Price to trailing twelve month operating cash flow for ANIK is currently 55.11, higher than 91.6% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of -56.47%, Anika Therapeutics Inc's debt growth rate surpasses just 7.38% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Anika Therapeutics Inc is reporting a growth rate of 193.8%; that's higher than 88.38% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Anika Therapeutics Inc, a group of peers worth examining would be STMP, KIQ, SCOR, KERN, and SANW.
  • ANIK's SEC filings can be seen here. And to visit Anika Therapeutics Inc's official web site, go to www.anikatherapeutics.com.

ANIK Valuation Summary

  • In comparison to the median Healthcare stock, ANIK's price/sales ratio is 60.35% lower, now standing at 4.5.
  • Over the past 243 months, ANIK's EV/EBIT ratio has gone down 34.5.
  • ANIK's price/sales ratio has moved up 3.9 over the prior 243 months.

Below are key valuation metrics over time for ANIK.

Stock Date P/S P/B P/E EV/EBIT
ANIK 2021-08-31 4.5 2.2 -49.0 -34.8
ANIK 2021-08-30 4.5 2.2 -48.8 -34.7
ANIK 2021-08-27 4.4 2.1 -47.9 -33.9
ANIK 2021-08-26 4.3 2.1 -46.8 -33.1
ANIK 2021-08-25 4.4 2.1 -47.3 -33.4
ANIK 2021-08-24 4.4 2.1 -47.8 -33.9

ANIK Growth Metrics

  • Its 4 year revenue growth rate is now at 25.58%.
  • The year over year price growth rate now stands at 25.8%.
  • The year over year revenue growth rate now stands at 3.25%.
Over the past 33 months, ANIK's revenue has gone up $28,832,000.

The table below shows ANIK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 136.819 10.315 -12.698
2021-03-31 129.352 9.589 -26.937
2020-12-31 130.457 13.065 -23.982
2020-12-31 130.457 13.065 -23.982
2020-09-30 127.541 23.5 -4.275
2020-06-30 125.544 27.686 11.336

ANIK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ANIK has a Quality Grade of B, ranking ahead of 75.13% of graded US stocks.
  • ANIK's asset turnover comes in at 0.363 -- ranking 120th of 183 Medical Equipment stocks.
  • EYE, MMM, and CNMD are the stocks whose asset turnover ratios are most correlated with ANIK.

The table below shows ANIK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.363 0.555 -0.097
2021-03-31 0.326 0.532 -0.187
2020-12-31 0.322 0.529 -0.144
2020-12-31 0.322 0.529 -0.144
2020-09-30 0.322 0.576 -0.027
2020-06-30 0.337 0.636 0.076

ANIK Price Target

For more insight on analysts targets of ANIK, see our ANIK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $49.67 Average Broker Recommendation 1.33 (Strong Buy)

ANIK Stock Price Chart Interactive Chart >

Price chart for ANIK

ANIK Price/Volume Stats

Current price $40.02 52-week high $48.37
Prev. close $40.48 52-week low $32.04
Day low $39.86 Volume 11,115
Day high $41.26 Avg. volume 109,189
50-day MA $40.83 Dividend yield N/A
200-day MA $40.71 Market Cap 577.21M

Anika Therapeutics Inc. (ANIK) Company Bio


Anika Therapeutics develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. The company was founded in 1983 and is based in Bedford, Massachusetts.


ANIK Latest News Stream


Event/Time News Detail
Loading, please wait...

ANIK Latest Social Stream


Loading social stream, please wait...

View Full ANIK Social Stream

Latest ANIK News From Around the Web

Below are the latest news stories about Anika Therapeutics Inc that investors may wish to consider to help them evaluate ANIK as an investment opportunity.

Tactoset® Injectable Bone Substitute Now FDA Cleared for Hardware Augmentation

510(k) clearance expands the capability of Tactoset for augmenting suture anchor fixationBEDFORD, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received an additional 510(k) clearance by the FDA for Tactoset® Injectable Bone Substitute. This new indication expands the use of Tactoset to include augmentation of hardware and the support of bone fragments d

Yahoo | September 14, 2021

Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

BEDFORD, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 15, 2021 at 2:00 p.m. ET.

Intrado Digital Media | September 7, 2021

Sports Medicine Market Analysis and Forecast 2028: By Keyplayes Smith & Nephew, Zimmer Biomet, Stryker, Breg, Inc., Medtronic, Bird & Cronin, Arthrex, Inc., Wright Medical Group N.V., Arthrosurface (a subsidiary of Anika Therapeutics, Inc.), Össur Corpor

Sports medicine market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2020 to 2027

OpenPR | September 3, 2021

Anika to Debut Joint Preservation Portfolio at the 2021 AAOS Annual Meeting

Anika, now combined with Arthrosurface and Parcus Medical, meets the evolving unmet needs of surgeons in the global joint preservation marketBEDFORD, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, will debut their full joint preservation and restoration product portfolio at the 2021 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting in San Diego, California September 1-3.

Yahoo | September 1, 2021

Worldwide Adhesion Barriers Industry to 2026 - Featuring Anika Therapeutics, Atrium Medical and Baxter International Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Adhesion Barriers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global adhesion barriers market exhibited moderate growth during 2015-2020. Looking forward, the publisher expects the global adhesion barriers market to grow at a CAGR of around 7% during the forecast period (2021-2026). An adhesion barrier refers to a liquid-, gel-or film-based medical implant t

Business Wire | August 18, 2021

Read More 'ANIK' Stories Here

ANIK Price Returns

1-mo -5.08%
3-mo -7.55%
6-mo -0.45%
1-year 13.24%
3-year -5.12%
5-year -13.19%
YTD -11.58%
2020 -12.71%
2019 54.27%
2018 -37.66%
2017 10.11%
2016 28.30%

Continue Researching ANIK

Here are a few links from around the web to help you further your research on Anika Therapeutics Inc's stock as an investment opportunity:

Anika Therapeutics Inc (ANIK) Stock Price | Nasdaq
Anika Therapeutics Inc (ANIK) Stock Quote, History and News - Yahoo Finance
Anika Therapeutics Inc (ANIK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.4894 seconds.